Sharp Debridement

Bleeding Control in Debridement

The presence of devitalized tissue in wounds may impair the healing process and removal of this tissue promotes wound healing (Saap and Falanga, 2002). The removal of devitalized tissue can be achieved by debridement and sharp debridement removes this necrotic tissue down to the level of well-vascularized tissue (Fife et al, 2012). Sharp debridement can increase the risk of bleeding and this risk is exacerbated by the use of anticoagulants in the aging population where chronic wounds are particularly prevalent. Clinical evaluations have been reported demonstrating positive outcomes of using OMNI-STAT in providing effective hemostasis after sharp debridement, including patients receiving anticoagulants (Snyder & Sigal, 2013).

The image at the top of this page shows a case study of the debridement of a diabetic foot ulcer in a patient on Coumadin^®.  This case study is described in the video by Dr. Matthew Regulski, DPM the Medical Director of Wound Institute of Ocean County.

 

 

In this next video Dr. Matthew Regulski explains the role of debridement and use of OMNI-STAT® hemostatic gauze and granules for the control of bleeding after surgical debridement.

 

 

See other posts relating to debridement here.